Nonmyeloablative second transplants are associated with lower nonrelapse mortality and superior survival than myeloablative second transplants

Biology of Blood and Marrow Transplantation

Volumn 16, Issue 12, 2010, Pages 1738-1746

  Hill, Brian T ^a   Bolwell, Brian J ^a   Rybicki, Lisa ^b   Dean, Robert ^a   Kalaycio, Matt ^a   Pohlman, Brad ^a   Tench, Shawnda ^b   Sobecks, Ronald ^a   Andresen, Steven ^a   Copelan, Edward ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Allogeneic; Autologous; Bone marrow Transplant; Myeloablative; Nonmyeloablative; Stem cell Transplant

Indexed keywords

ALEMTUZUMAB; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ETOPOSIDE; FLUDARABINE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CHRONIC MYELOID LEUKEMIA; FEMALE; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HAZARD RATIO; HUMAN; LEUKEMIA RELAPSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYELOABLATIVE CONDITIONING; NONMYELOABLATIVE STEM CELL TRANSPLANTATION; PROGNOSIS; RISK FACTOR; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; DISEASE-FREE SURVIVAL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RECURRENCE; REOPERATION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78149409762     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2010.06.009     Document Type: Article

References (16)

1. Copelan E.A. Hematopoietic stem-cell transplantation. N Engl J Med 2006, 27(354):1813-1826.
2. Bosi A., Laszlo D., Labopin M., et al. Second allogeneic bone marrow transplantation in acute leukemia: results of a survey by the european cooperative group for blood and marrow transplantation. J Clin Oncol 2001, 19:3675-3684.
3. Arfons L.M., Tomblyn M., Rocha V., Lazarus H.M. Second hematopoietic stem cell transplantation in myeloid malignancies. Curr Opin Hematol 2009, 16:112-123.
4. Shaw B.E., Mufti G.J., Mackinnon S., et al. Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant. Bone Marrow Transplant 2008, 42:783-789.
5. Radich J.P., Gooley T., Sanders J.E., Anasetti C., Chauncey T., Appelbaum F.R. Second allogeneic transplantation after failure of first autologous transplantation. Biol Blood Marrow Transplant 2000, 6:272-279.
6. Platzbecker U., Binder M., Schmid C., Rutt C., Ehninger G., Bornhauser M. Second donation of hematopoietic stem cells from unrelated donors for patients with relapse or graft failure after allogeneic transplantation. Haematologica 2008, 93:1276-1278.
7. Guardiola P., Kuentz M., Garban F., et al. Second early allogeneic stem cell transplantations for graft failure in acute leukaemia, chronic myeloid leukaemia and aplastic anaemia. french society of bone marrow transplantation. Br J Haematol 2000, 111:292-302.
8. Byrne B.J., Horwitz M., Long G.D., et al. Outcomes of a second non-myeloablative allogeneic stem cell transplantation following graft rejection. Bone Marrow Transplant 2008, 41:39-43.
9. Chewning J.H., Castro-Malaspina H., Jakubowski A., et al. Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failure. Biol Blood Marrow Transplant 2007, 13:1313-1323.
10. Fernandes J., Rocha V., Robin M., et al. Second transplant with two unrelated cord blood units for early graft failure after haematopoietic stem cell transplantation. Br J Haematol 2007, 137:248-251.
11. Narimatsu H., Kami M., Miyakoshi S., et al. Graft failure following reduced-intensity cord blood transplantation for adult patients. Br J Haematol 2006, 132:36-41.
12. Ringden O., Labopin M., Gorin N.C., et al. The dismal outcome in patients with acute leukaemia who relapse after an autograft is improved if a second autograft or a matched allograft is performed. acute leukaemia working party of the european group for blood and marrow transplantation (EBMT). Bone Marrow Transplant 2000, 25:1053-1058.
13. Eapen M., Giralt S.A., Horowitz M.M., et al. Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant. Bone Marrow Transplant 2004, 34:721-727.
14. Sobecks R.M., Dean R., Rybicki L.A., et al. 400 cGy TBI with fludarabine for reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2008, 42:715-722.
15. Blaise D., Vey N., Faucher C., Mohty M. Current status of reduced-intensity-conditioning allogeneic stem cell transplantation for acute myeloid leukemia. Haematologica 2007, 92:533-541.
16. Kim D.H., Sohn S.K., Baek J.H., et al. Retrospective multicenter study of allogeneic peripheral blood stem cell transplantation followed by reduced-intensity conditioning or conventional myeloablative regimen. Acta Haematol 2005, 113:220-227.